We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The FDA has handed Mylan and Fujifilm Kyowa Kirin Biologics approval for their biosimilar of Humira (adalimumab), marking the agency’s sixth approval for a biosimilar of AbbVie’s blockbuster immunosuppressive drug. Read More
In a win for AbbVie, a preliminary ruling from a U.S. International Trade Commission (USITC) judge could lead to a 10-year ban on a competitor’s Botox treatment. Read More
Type 2 Diabetes drug metformin is the latest medicine to be recalled due to unacceptable levels of the probable human carcinogen NDMA (N-Nitrosodimethylamine). Read More
The House Appropriations Committee has signed off on a fiscal 2021 measure that would give the FDA $3.2 billion in funding, an increase of $40.8 million from fiscal 2020, and give the agency power to require recalls. The legislation is now headed to the full House for consideration, although no date has been set. Read More
Moderna has tapped Spanish pharma company Laboratorios Farmacéuticos Rovi to conduct large-scale, commercial fill-finish manufacturing of its COVID-19 vaccine candidate in order to bolster international supply. Read More
More than 20 leading drugmakers have teamed up on a new program to develop innovative antibiotics in the coming decade to help curb the global threat of antibiotic-resistant infections. Read More